Patient Characteristics
| Characteristic | Data |
| Total patients | 280 |
| Age (y) | 66.8 (38–84) |
| T-stage | |
| T1 | 0 (0.0%) |
| T2 | 238 (85.0%) |
| T3 | 33 (11.8%) |
| T4 | 9 (3.2%) |
| Unknown | 0 (0%) |
| GS | |
| ≤6 (ISUP grade 1) | 35 (12.5%) |
| 7 (ISUP grade 2/3) | 102 (36.4%) |
| 8 (ISUP grade 4) | 52 (18.6%) |
| ≥9 (ISUP grade 5) | 83 (29.6%) |
| Unknown | 8 (2.9%) |
| iPSA (ng/mL) | 11.8 (1.4–511) |
| Risk-group according to d’Amico (1) | |
| Low | 6 (2.2%) |
| Intermediate | 39 (13.9%) |
| High | 235 (83.9%) |
| Unknown | 0 (0%) |
| Further treatment | |
| Surgery | 97 (34.6%) |
| Radiotherapy | 52 (18.6%) |
| Systemic therapy | 20 (7.1%) |
| Unknown | 111 (39.7%) |
Qualitative data are expressed as numbers followed by percentages in parentheses; continuous data are expressed as median followed by range in parentheses.